Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft—no benefit of combination therapy-Reference-Cited by-同舟云学术

Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft—no benefit of combination therapy

Published:2012-09-15 Issue:3 Volume:28 Page:385-398
ISSN:0179-1958
Container-title:International Journal of Colorectal Disease
language:en
Short-container-title:Int J Colorectal Dis

Author:

Wehler Thomas C.,Hamdi Swaantje,Maderer Annett,Graf Claudine,Gockel Ines,Schmidtmann Irene,Hainz Michael,Berger Martin R.,Theobald Matthias,Galle Peter R.,Moehler Markus,Schimanski Carl C.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00384-012-1551-2

Reference34 articles.

1. Greenlee RT, Murray T, Bolden S, Wingo PA et al (2000) Cancer statistics, 2000. CA Cancer J Clin 50:7–33

2. Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK (2003) Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 95:1276–1299

3. August DA, Ottow RT, Sugarbaker PH (1984) Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev 3:303–324

4. Douillard JY, Siena S, Cassidy J, Tabernero J, Burkes R, Barugel M, Humblet Y, Bodoky G, Cunningham D, Jassem J, Rivera F, Kocakova I et al (2010) Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J Clin Oncol 28(31):4697–7705

5. Sobrero A, Ackland S, Clarke S, Perez-Carrion R, Chiara S, Gapski J, Mainwaring P, Langer B, Young S (2009) Phase IV study of bevacizumab in combination with infusional fluorouracil, leucovorin and irinotecan (FOLFIRI) in first-line metastatic colorectal cancer. Oncology 77:113–119

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 6-Shogaol improves sorafenib efficacy in colorectal cancer cells by modulating its cellular accumulation and metabolism;Pathology - Research and Practice;2024-10

2. Effects of 5-fluorouracil, thymoquinone and mammary stem cells’ exosomes on in vitro cultured breast cancer cells;Open Veterinary Journal;2024

3. Integrating cutting-edge technologies: AI, IoT, blockchain and nanotechnology for enhanced diagnosis and treatment of colorectal cancer - A review;Journal of Drug Delivery Science and Technology;2024-01

4. Therapeutic efficacy of sorafenib and plant-derived phytochemicals in human colorectal cancer cells;BMC Complementary Medicine and Therapies;2023-06-26

5. Co-delivery of sorafenib and metformin from amphiphilic polypeptide-based micelles for colon cancer treatment;Frontiers in Medicine;2022-10-11